News and Events

View our monthly calendar for upcoming innovation information sessions, seminars, symposia and other events hosted by Enterprise Innovation and selected ecosystem partners.

GoT-ChA: A New Tool for Detailing How Gene Mutations Affect Cells

May 8, 2024

A team co-led by researchers at Weill Cornell Medicine and the New York Genome Center has developed an advanced method for revealing how gene mutations disrupt the normal packaging of DNA. These structural changes, which alter patterns of gene activity in a cell, are known as epigenetic changes and can lead to malignancy.

Daedalus Fund Aims to Advance Translational Studies to Next Stages

April 30, 2024

The Daedalus Fund for Innovation, a unique de-risking program of Weill Cornell Medicine Enterprise Innovation, announced its recipients for funding this year.

Gut Microbiota Acts Like an Auxiliary Liver

April 23, 2024

Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study by Weill Cornell Medicine investigators. The study, published April 23 in Cell Host & Microbe, adds to the growing list of ways in which the microbiome influences physiology, and could lead to new strategies to treat conditions such as inflammatory bowel disease and diabetes.

Tracking a Protein’s Fleeting Shape Changes

April 17, 2024

Researchers at Weill Cornell Medicine have developed a powerful, new technique to generate “movies” of changing protein structures and speeds of up to 50 frames per second.

Researchers Produce Grafts that Replicate the Human Ear

April 1, 2024

Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural. The study, published online in Acta Biomaterialia on March 16, offers the promise of grafts with well-defined anatomy and the correct biomechanical properties for those who are born with a congenital malformation or who lose an ear later in life.

2024 Health Hackathon Yields Innovative Solutions for Enhancing Patient Safety

March 21, 2024

The 2024 Health Hackathon brought together 185 students with diverse backgrounds from Cornell and 26 other universities—in just 36 hours, they addressed critical safety challenges facing patients today.

NSF Awards Grant for Evolution-inspired Design of Therapeutic RNAs

March 19, 2024

A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.

Advancing Neurosurgical Innovations Through Mentor-Mentee Collaborations

March 11, 2024

Dr. Susan Pannullo, professor of clinical neurological surgery, considers it an honor and duty to support the next generation of neurosurgeons and help them reach their personal and professional goals. She met a like-minded mentee, Dr. Mohammed Fouda, fellow in neurological surgery. Both doctors have a keen interest in advancing neurosurgical technologies and team up to improve patient outcomes.

Conference Showcases Biomedical Innovation at the Intersection of Business and Science

March 7, 2024

The 2024 Startup Symposium & InvestConnect Conference celebrated scientific inquiry and the entrepreneurial spirit.

Structural Study Points the Way to Better Malaria Drugs

January 18, 2024

Structural insights into a potent antimalarial drug candidate’s interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.

Read the latest news about Enterprise Innovation and Weill Cornell Medicine.

Weill Cornell Medicine Enterprise Innovation 1155 York Ave. New York, NY 10065 Phone: (646) 962-7045